LETTER FROM LEADERSHIP

Letter from Leadership 2025

At Casey Eye Institute, innovation meets compassion in the pursuit of advancing eye health and vision care. From groundbreaking research to transformative technologies like telehealth and AI, we are committed to ending preventable blindness. Discover how our leadership and collaboration are shaping the future of eye care.

Advancing Imaging

Advancing Uveitis Care Through AI and Ultra-High Resolution OCT

At OHSU's Casey Eye Institute, researchers are combining artificial intelligence with ultra-high-resolution optical coherence tomography imaging to tackle uveitis. Using this breakthrough approach, they are not only able to count white blood cells, but also identify their location and type.

Inside the Lab

Lipid Nanoparticles Revolutionize Gene Therapy for Eye Diseases

Unlocking the future of vision care, Dr. Renee Ryals and her team are revolutionizing gene therapy with cutting-edge lipid nanoparticle technology. The new LNP delivery systems may expand therapeutics options for genetic eye disease treatment and offer hope to patients.

Data-Driven Medicine

Transforming Glaucoma Detection

Research team is pioneering the future of glaucoma detection with an AI-powered tool that assesses glaucoma risk using electronic health record data. This innovative approach enables early identification without the need for specialized eye exams, expanding access to essential eye care.

Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research.
© 2001-2022 Oregon Health & Science University. OHSU is an equal opportunity affirmative action institution.
CONTACT US
515 SW Campus Drive, Portland, Oregon 97239
503-494-3000
Innovations Archive